Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Vinny57on Dec 09, 2018 9:51pm
93 Views
Post# 29089945

RE:Ambulance chasers

RE:Ambulance chasers
Leggy67 wrote: The us legal stuff is garbage- by Jan 11 the sp is going to be north of $10.50 and I can just see a judge listening to these whiners "okay let me understand you sold your shares in Aphria at a loss because of a bogus short seller report and the share price is now back to where is was before you sold - yeah case dismissed "

 
This is correct.  The only change I would make is, if all goes well this week, the share price will be north of $10.50 post the Q2 Report.
Bullboard Posts